Muscular dystrophy and cancer-associated muscle wasting share dystrophin dysfunction
14th Nov 2005, 17:10 GMT
A new study provides important insight into the mechanisms of a muscle wasting disorder that interferes with treatment for cancer and has a negative impact on patient survival. The research, published in the November issue of Cancer Cell, describes an unexpected link between muscular dystrophy and muscle wasting associated with cancer, and suggests a potential strategy for development of therapies to combat cancer-associated muscle wasting.
Muscular dystrophy and cancer-associated muscle wasting share dystrophin dysfunction related news:
- Muscular dystrophy and cancer-associated muscle wasting share dystrophin dysfunction — Medical News Today RSS/XML Feed
- Cancer wasting, muscular dystrophy show common change — EurekAlert! - Biology
- Muscle wasting similar in cancer and MD — Health News
- Better understanding of cancer cachexia — News-Medical News Feed
- Muscle wasting similar in cancer and MS — Monsters and Critics News
- [Biochemistry] The structural basis of myotonic dystrophy from the crystal structure of CUG repeats — Proceedings of the National Academy of Sciences recent issues
- New form of cancer gene regulation discovered — Medical News Today RSS/XML Feed
- UTMB opens clinic to treat sexual dysfunction — The Daily News: News
- Giants co-owner Tisch, 79, dies from brain cancer — ESPN.com
- Smaller prostate size, more aggressive cancer (Reuters) — Yahoo! News: Health News
Latest news from EurekAlert! - Cancer:
- Targeted cancer drugs may work by disrupting balance of cellular signals
- Studies examine colorectal cancer screening rates
- Higher red meat intake may increase risk for certain breast cancers
- U-M researchers use nanoparticles to target brain cancer
- 'Trojan Horse' agent halts bone metastasis in mice
- Increased patient demand for prostate test has serious implications for cancer services
- Novel regulatory mechanism identified for key tumor suppressor p53